DEA: Cocaine/Fentanyl Combination in Pennsylvania

The Drug Enforcement Administration – Philadelphia Field Division conducted an assessment of laboratory-analyzed drug seizures found to contain cocaine with and without the presence of fentanyl, as well as combined cocaine and fentanyl presence in overdose death toxicology reporting. This analysis was conducted in response to reported increases in the co-occurrence of cocaine and fentanyl […]

Read More…

DEA: Drug Presence in Pennsylvania 1999-2016

The Drug Enforcement Administration – Philadelphia Field Division conducted a review of laboratory-analyzed drug seizures for the Commonwealth of Pennsylvania. The resulting analysis of this data formed the basis for estimating the level of drug presence in Pennsylvania and highlighted trends in drug availability between 1999 and 2016. Click here to access the document. […]

Read More…

DEA: 2017 National Drug Threat Assessment

The 2017 National Drug Threat Assessment is a comprehensive strategic assessment of the threat posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. The report combines law enforcement reports, public health data, open source reporting, and intelligence from other government agencies to determine which substances and criminal […]

Read More…

Our Partners

Pennsylvania Psychiatric Society
Pennsylvania Dental Association
DEA 360 Strategy
Pennsylvania District Attorneys Association
The Hospital and Healthsystem Association of Pennsylvania
Pennsylvania Pharmacists Association
Pennsylvania Medical Society